BIM
ORKA

BlackRock Investment Management’s Oruka Therapeutics ORKA Stock Holding History

BlackRock Investment Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3K Hold
5
– – ﹤0.01% 3843
2016
Q3 		$3K Hold
5
– – ﹤0.01% 3854
2016
Q2 		$3K Buy
+5
New +$3.7K ﹤0.01% 3936
2015
Q2 		– Sell
-2
Closed -$2K – 4205
2015
Q1 		$2K Hold
2
– – ﹤0.01% 3988
2014
Q4 		$3K Hold
2
– – ﹤0.01% 4012
2014
Q3 		$4K Hold
2
– – ﹤0.01% 3948
2014
Q2 		$4K Buy
+2
New +$4.65K ﹤0.01% 3932

Other funds holding ORKA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACP
Aveo Capital Partners Englewood, Colorado $601M AUM 5.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock Investment Management's ORKA Position: Q4 2016 in Review

BlackRock Investment Management held its Oruka Therapeutics (ORKA) position steady in Q4 2016 at 5 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #3843.

BlackRock Investment Management first reported a position in ORKA in Q2 2014 and has held it in 7 quarters since. The position peaked at $4K in Q3 2014. 16 funds tracked by Wall St. Rank hold ORKA as of Q4 2016.

  • BlackRock Investment Management held 5 shares of Oruka Therapeutics worth $3K as of Q4 2016.
  • BlackRock Investment Management left its Oruka Therapeutics share count unchanged in Q4 2016.
  • Oruka Therapeutics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3843 holding.
  • BlackRock Investment Management first reported a position in Oruka Therapeutics in Q2 2014 and has held it in 7 quarters since.
  • BlackRock Investment Management's Oruka Therapeutics position peaked at $4K in Q3 2014.
  • 16 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.